Bright Horizons Family Solutions Earnings Call Transcripts
Fiscal Year 2026
-
The meeting covered director elections, executive compensation, and auditor ratification, with all proposals approved by majority vote. No shareholder questions were received during the session.
-
Q1 2026 saw 7% revenue growth, strong Back-Up Care performance, and margin expansion in Full Service, offset by significant headwinds in Australia. Full-year guidance was reaffirmed, with Back-Up Care growth expectations raised and continued focus on operational efficiency and capital returns.
Fiscal Year 2025
-
Q4 and full-year 2025 results exceeded expectations, with 9% revenue growth and 31% adjusted EPS growth year-over-year. Back-Up Care and Ed Advisory segments led performance, while Full Service saw steady enrollment and ongoing portfolio rationalization. 2026 guidance anticipates continued revenue and earnings growth, with robust cash flow and share repurchases supporting a strong balance sheet.
-
Q3 revenue rose 12% to $803M and Adjusted EPS jumped 41% to $1.57, driven by strong Back-Up Care and solid performance across all segments. Full-year guidance was raised, with revenue expected at $2.925B and Adjusted EPS at $4.48-$4.53.
-
Q2 2025 saw 9% revenue growth and 22% adjusted EPS growth, with strong performance across all segments and raised full-year guidance. Backup care and U.K. operations were standout contributors, and margin expansion was driven by enrollment gains and operational leverage.
-
Revenue grew 7% to $666M with adjusted EPS up 51%, driven by strong segment performance and margin expansion. Guidance was raised for revenue growth to 6.5%-8.5%, while enrollment growth assumptions were trimmed due to macro uncertainty.
Fiscal Year 2024
-
Fourth quarter and full-year results exceeded expectations, driven by strong Back-Up Care growth and improved Full Service performance. 2025 guidance calls for 6%-8% revenue growth and 15%-20% adjusted EPS growth, with continued margin expansion and a path to break-even in the U.K.
-
Q3 revenue and adjusted EPS exceeded expectations, led by strong backup care growth and improved U.K. performance. Full-year guidance was raised, with continued low single-digit enrollment growth and disciplined pricing expected into 2025.
-
Q2 2024 saw 11% revenue growth and 38% higher adjusted EPS, driven by strong full-service and backup care performance. Full-year guidance was raised, with improved U.K. results and ongoing center rationalization supporting margin gains.